SUBLEASE AGREEMENTSublease Agreement • May 10th, 2017 • Merrimack Pharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
Contract Type FiledMay 10th, 2017 Company Industry JurisdictionThis Sublease Agreement (“Sublease”), dated as of April 3, 2017 (the “Effective Date”), is by and between MERRIMACK PHARMACEUTICALS, INC., a Delaware corporation, having a mailing address at One Kendall Square, Suite B7201, Cambridge, MA 02139 (“Sublandlord”), and IPSEN BIOSCIENCE, INC., a Massachusetts corporation, domiciled at 650 East Kendall Street, Cambridge, MA 02142 (“Subtenant”).
FIFTH AMENDMENT OF LEASELease • May 10th, 2017 • Merrimack Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledMay 10th, 2017 Company IndustryThis Fifth Amendment of Lease (this “Fifth Amendment”) is made and entered into as of April 3, 2017 (the “Effective Date”), by and between ARE-MA REGION NO. 59, LLC, a Delaware limited liability company (“Landlord”), as successor-in-interest to DWF IV One Kendall, LLC, as successor-in-interest to RB Kendall Fee, LLC (“Original Landlord”), and MERRIMACK PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”), with reference to the following: